B00.4 Herpesviral encephalitis

Name of the Condition

• Herpesviral encephalitis

Summary

Herpesviral encephalitis is a serious neurological condition caused by the herpes simplex virus (HSV) and characterized by inflammation of the brain. It is the most common cause of sporadic viral encephalitis in developed countries and typically presents with acute or subacute onset of neurological symptoms. The condition requires prompt medical attention due to its potential for severe morbidity and mortality if left untreated.

Causes

The condition is caused by infection with the herpes simplex virus (HSV), most commonly HSV-1, which can invade the central nervous system and cause inflammation of brain tissue. The virus may reactivate from a latent state in cranial nerves or spread hematogenously to the brain. Rarely, HSV-2 can also cause encephalitis, particularly in neonates or immunocompromised individuals.

Risk Factors

• Immunocompromised states, such as HIV/AIDS, chemotherapy, or chronic steroid use.
• Age, with higher incidence in neonates and older adults.
• Prior HSV infection, as the virus may reactivate from latency.
• Trauma or neurosurgical procedures that disrupt the blood-brain barrier.

Symptoms

• Altered mental status, confusion, or behavioral changes.
• Headache, fever, and stiff neck.
• Seizures or focal neurological deficits.
• Aphasia, memory impairment, or personality changes.
• Photophobia and other signs of meningeal irritation.

Diagnosis

Diagnosis involves a combination of clinical evaluation, neuroimaging (e.g., MRI or CT scan), and laboratory testing. Cerebrospinal fluid (CSF) analysis may show elevated white blood cells and protein, with PCR testing for HSV DNA being the most specific diagnostic tool. EEG may reveal characteristic temporal lobe abnormalities, and brain biopsy is rarely required.

Treatment Options

• Intravenous antiviral therapy (e.g., acyclovir) initiated promptly to reduce viral replication and improve outcomes.
• Supportive care, including management of seizures, increased intracranial pressure, and other complications.
• Adjunctive therapies, such as corticosteroids in select cases, to reduce inflammation.

Prognosis and Follow-Up

Prognosis depends on the timeliness of treatment and the severity of initial symptoms. Early antiviral therapy significantly improves survival rates, but neurological sequelae (e.g., memory loss, cognitive impairment) may persist. Follow-up includes monitoring for recurrence, rehabilitation for residual deficits, and long-term neurological assessments.

Complications

• Permanent neurological damage, including cognitive impairment or motor deficits.
• Increased intracranial pressure leading to herniation.
• Seizure disorders or epilepsy.
• Death in severe or untreated cases.

Lifestyle & Prevention

• Avoiding close contact with individuals during active HSV outbreaks.
• Maintaining good hygiene practices to reduce transmission risk.
• Immunocompromised individuals should take precautions to prevent reactivation.
• Prompt treatment of HSV infections to reduce the risk of dissemination.

When to Seek Professional Help

Seek immediate medical attention if experiencing sudden neurological symptoms (e.g., confusion, seizures, severe headache) or signs of meningitis, especially in the context of a known or suspected HSV infection.

Tips for Medical Coders

Document the clinical confirmation of herpesviral encephalitis, including laboratory or imaging findings supporting the diagnosis. Ensure the code B00.4 is assigned when the condition is specifically identified as encephalitis caused by herpes simplex virus. Differentiate from other viral encephalitides or non-infectious causes of brain inflammation based on clinical and diagnostic criteria.